Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BCL7A anticorps (Middle Region)

Cet anticorps Lapin Polyclonal détecte spécifiquement BCL7A dans WB. Il présente une réactivité envers Humain.
N° du produit ABIN632344

Aperçu rapide pour BCL7A anticorps (Middle Region) (ABIN632344)

Antigène

Voir toutes BCL7A Anticorps
BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))

Reactivité

  • 28
  • 7
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Humain

Hôte

  • 27
  • 1
Lapin

Clonalité

  • 28
Polyclonal

Conjugué

  • 16
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp BCL7A est non-conjugé

Application

  • 21
  • 12
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Épitope

    • 10
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Middle Region

    Specificité

    BCL7 A antibody was raised against the middle region of BCL7

    Purification

    Affinity purified

    Immunogène

    BCL7 A antibody was raised using the middle region of BCL7 corresponding to a region with amino acids CGSEVTTPENSSSPGMMDMHDDNSNQSSIADASPIKQENSSNSSPAPEPN
  • Indications d'application

    WB: 1 µg/mL
    Optimal conditions should be determined by the investigator.

    Commentaires

    BCL7A Blocking Peptide, (ABIN937090), is also available for use as a blocking control in assays to test for specificity of this BCL7A antibody

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Lyophilized powder. Add distilled water for a 1 mg/mL concentration of BCL0 antibody in PBS

    Concentration

    Lot specific

    Buffer

    PBS

    Conseil sur la manipulation

    Avoid repeated freeze/thaw cycles.
    Dilute only prior to immediate use.

    Stock

    4 °C/-20 °C

    Stockage commentaire

    Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
  • Antigène

    BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))

    Autre désignation

    BCL7A

    Sujet

    This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.

    Poids moléculaire

    25 kDa (MW of target protein)
Vous êtes ici:
Chat with us!